Attached files

file filename
S-1 - S-1 - Neos Therapeutics, Inc.a2225009zs-1.htm
EX-21.1 - EX-21.1 - Neos Therapeutics, Inc.a2225009zex-21_1.htm
EX-10.12 - EX-10.12 - Neos Therapeutics, Inc.a2225009zex-10_12.htm
EX-3.1 - EX-3.1 - Neos Therapeutics, Inc.a2225009zex-3_1.htm
EX-10.1 - EX-10.1 - Neos Therapeutics, Inc.a2225009zex-10_1.htm
EX-10.6 - EX-10.6 - Neos Therapeutics, Inc.a2225009zex-10_6.htm
EX-4.3 - EX-4.3 - Neos Therapeutics, Inc.a2225009zex-4_3.htm
EX-10.8 - EX-10.8 - Neos Therapeutics, Inc.a2225009zex-10_8.htm
EX-10.9 - EX-10.9 - Neos Therapeutics, Inc.a2225009zex-10_9.htm
EX-10.3 - EX-10.3 - Neos Therapeutics, Inc.a2225009zex-10_3.htm
EX-10.2 - EX-10.2 - Neos Therapeutics, Inc.a2225009zex-10_2.htm
EX-10.7 - EX-10.7 - Neos Therapeutics, Inc.a2225009zex-10_7.htm
EX-10.10 - EX-10.10 - Neos Therapeutics, Inc.a2225009zex-10_10.htm
EX-4.2 - EX-4.2 - Neos Therapeutics, Inc.a2225009zex-4_2.htm
EX-3.3 - EX-3.3 - Neos Therapeutics, Inc.a2225009zex-3_3.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the use in this Registration Statement on Form S-1 of Neos Therapeutics, Inc. and Subsidiaries of our report dated April 24, 2015, relating to our audits of the consolidated financial statements, appearing in the Prospectus, which is part of this Registration Statement.

We also consent to the reference to our firm under the caption "Experts" in such Prospectus.

/s/ McGladrey LLP

New York, New York
June 19, 2015